At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Feb 22, 2026 at 19:00 ET
Two C-suite executives at KalVista Pharmaceuticals, the CFO and Chief Commercial Officer, sold shares worth $89,385 in the past week, following recent option exercises. The sales are part of a planned disposition after exercising options, not open-market selling, and no new insider buying was detected.
- CFO Brian Piekos sold 1,767 shares for $27,507 at $15.57/share on 2026-02-23
- CCO Nicole Sweeny sold 3,975 shares for $61,878 at $15.57/share on 2026-02-23
- Both executives exercised stock options on 2026-02-21 and 2026-02-22 (totaling 11,250 shares) at $0 price, indicating prior grant exercise
- Total insider sell activity in cluster: $89,385
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access